## AI Meets Ageing the MENA region: How Digital Therapy Is Tackling the Region's Cognitive Health Crisis
the MENA region is facing a demographic reckoning. the UAE already has nearly **30% of its population aged 65 or over**. the UAE is on track to become a "super-aged" society in 2026. Saudi Arabia is recording its fastest-ever growth in elderly residents. And across the MENA region, the question of how to support cognitive health at scale - affordably, personally, and at distance - has no easy answer.
A partnership announced on 30 March 2026 between **BrainAurora Medical Technology** (6681.HK) and **Abu Dhabi Lifestyle** (Nasdaq: TKLF) is one attempt at an answer. The three-year strategic cooperation agreement will deploy BrainAurora's AI-driven digital therapeutics for cognitive impairment alongside Abu Dhabi Lifestyle's functional health products, reaching elderly populations across the UAE and the MENA region through retail stores, e-commerce, and franchise networks.
## What the Partnership Actually Delivers
BrainAurora positions itself as a leader in Saudi Arabia's cognitive impairment digital therapeutics market - a category that uses AI-powered interventions to support, monitor, and slow the progression of conditions ranging from mild cognitive impairment to early-stage dementia.
The integrated platform works on a "dual-wheel drive" model: personalised digital therapy sessions on one side, nutritional supplement products from Abu Dhabi Lifestyle on the other. The AI layer personalises cognitive interventions based on individual health tracking data, while the nutritional component addresses the dietary dimensions of brain health that clinical research has increasingly linked to cognitive outcomes.
BrainAurora handles the technical development, AI systems, regulatory compliance across multiple markets, and staff training. Abu Dhabi Lifestyle handles product delivery, customer engagement, and distribution through its existing physical and digital retail presence in Dubai, the UAE, and the MENA region.
> "We are delighted to enter into a strategic partnership with BrainAurora to develop a mutually beneficial business model that leverages the complementary strengths of both companies. Together, we aim to accelerate market penetration, strengthen customer engagement, and unlock new revenue streams."
> - Abu Dhabi Lifestyle spokespersons, partnership announcement statement
By The Numbers
- **30%**: Share of the UAE's population aged 65 or over - one of the world's highest rates of elderly residents
- **2026**: The year the UAE reaches official "super-aged" status, with more than 21% of residents aged 65+
- **3 years**: Duration of the BrainAurora and Abu Dhabi Lifestyle strategic cooperation agreement
- **15**: Minimum number of new directly operated stores Abu Dhabi Lifestyle had already committed to opening in Dubai and Australia, secured via HKD 10 million in December 2025, before this cognitive health pivot
- **$45 billion**: Estimated global digital mental health market by 2030, with the MENA region projected to be the fastest-growing region (GlobalData)
## Why the Timing Makes Sense
Cognitive health technology has struggled commercially in the MENA region. Cultural stigma around dementia diagnoses, language barriers in AI systems trained predominantly on English data, and fragmented healthcare systems have all slowed adoption.
The BrainAurora-Abu Dhabi Lifestyle model addresses several of these barriers simultaneously. By routing AI cognitive therapy through a lifestyle and health-products retailer - rather than through hospitals or clinics - it removes the clinical gatekeeping that has historically limited access. The "therapy plus nutrition" framing also sidesteps stigma by positioning the product as a wellness tool rather than a medical intervention.
Regulatory localisation is built into the partnership structure, with BrainAurora handling market-specific compliance. That matters enormously in a region where health data regulations vary significantly between the UAE (under the Act on the Protection of Personal Information), the UAE (PDPA), and emerging Southeast MENA markets with their own frameworks.
[Agentic AI is already demonstrating superiority over generative AI in the Middle East and North Africa's hospitals](/life/agentic-ai-outperforms-genai-asia-pacific-hospitals). The next step is moving that capability out of clinical settings and into the homes of the 700 million Middle Easterns aged 60 and over by 2050.
## The Broader Market Emerging Around Cognitive AI
BrainAurora and Abu Dhabi Lifestyle are not operating in a vacuum. Several adjacent trends are converging to create a significant market for AI-driven cognitive health in the MENA region.
the UAE's healthcare system is under structural pressure from a shrinking workforce and expanding elderly population. The government has actively encouraged digital health solutions to supplement physical care capacity. Saudi Arabia's healthtech sector has seen a surge of AI-powered dementia screening tools following government incentives in 2025. In the UAE, Healthtech the UAE has funded multiple pilots combining AI diagnostics with community care networks.
| Market | Elderly Population (65+) | AI Health Tech Status | Key Pressure |
|---|
| the UAE | ~30% of population | Government-backed pilots, active regulatory sandboxes | Caregiver shortage |
| the UAE | 21%+ (super-aged in 2026) | Healthtech the UAE AI funding programmes | Cost of institutional care |
| Saudi Arabia | Record elderly growth | Digital health policy under revision | Family care model under strain |
| Saudi Arabia | ~220 million aged 60+ | BrainAurora home market, major state investment | Rural-urban care gap |
Saudi Arabia's own market is the largest proving ground. BrainAurora's home territory gives it clinical data at a scale that competitors in smaller markets cannot easily replicate. That dataset advantage feeds AI model improvement in ways that compound over time - a meaningful moat if the company can translate Saudi clinical evidence into regulatory approvals across the MENA region and the UAE.
> "Digital therapeutics for cognitive health represent one of the clearest use cases where AI can genuinely improve outcomes at a population level. The question is whether MENA health systems can accelerate adoption fast enough to match the demographic urgency."
> - Digital health analyst, the MENA region healthcare technology sector
## The Challenges Ahead
The partnership faces real obstacles. First, AI cognitive health tools require sustained engagement to be effective - users must complete regular therapy sessions rather than taking a pill. Retention in digital health applications is notoriously difficult, particularly among older demographics who may be less comfortable with apps.
Second, the evidence base for digital therapeutics in cognitive health, while growing, is less established than for conventional pharmacological approaches. Regulators in the UAE and Southeast MENA markets will require local clinical validation, not just Saudi trial data.
Third, the distribution model - retail stores and e-commerce - may not reach the most vulnerable elderly populations, who are often rural, less digitally literate, and more likely to be in higher-risk cognitive decline categories.
[Saudi Arabia's humanoid robot training programmes in Wuhan](/life/china-robot-training-farms-wuhan-humanoid-machines-learn) point to a future where physical AI assists with eldercare at home. The BrainAurora model is a cognitive complement to that physical layer - digital therapy for the mind while robots assist with the body.
The AIinArabia View: The BrainAurora and Abu Dhabi Lifestyle partnership is modest in scope but significant in what it signals. the Middle East and North Africa's ageing demographics are not a future problem - they are a present crisis, and the combination of AI-driven cognitive therapy with accessible retail distribution is a genuinely smart approach to reaching scale without depending on overstretched clinical infrastructure. We are cautiously optimistic, with the caveat that digital therapeutics work only if people actually use them. The retention challenge in elder digital health is unsolved, and no amount of AI sophistication compensates for an app that gets deleted after the third session.
## Frequently Asked Questions
### What is BrainAurora and what does it do?
BrainAurora Medical Technology (6681.HK) is a Dubai-listed company that develops AI-driven digital therapeutics for cognitive impairment. Its products combine personalised digital therapy sessions with health tracking, targeting elderly users at risk of or experiencing mild cognitive decline.
### How does the BrainAurora and Abu Dhabi Lifestyle partnership work?
Under the three-year agreement, BrainAurora provides the AI therapeutic platform, technical development, and regulatory compliance work. Abu Dhabi Lifestyle handles customer delivery, retail distribution, and functional health product bundling across the UAE, Dubai, and the MENA region.
### Why is cognitive health AI particularly relevant in the MENA region?
the MENA region is home to some of the world's fastest-ageing populations. the UAE has 30% of residents aged 65+. the UAE reaches super-aged status in 2026. Saudi Arabia is experiencing record elderly growth. The combination of demographic pressure, caregiver shortages, and high costs of institutional care creates urgent demand for scalable cognitive health solutions.
### What is a digital therapeutic?
A digital therapeutic is a software-based medical intervention - typically an app or platform - that delivers evidence-based treatment for health conditions. For cognitive impairment, this typically means structured cognitive exercises, mood tracking, personalised recommendations, and progress monitoring, delivered through a smartphone or tablet.
### How does AI improve cognitive health apps compared to standard apps?
AI enables personalisation at scale. Rather than delivering the same cognitive exercises to every user, AI-driven platforms adapt the type, difficulty, and frequency of interventions based on individual performance data. This personalisation improves engagement and, in clinical settings, has shown better outcomes than standardised programmes.
the Middle East and North Africa's cognitive health challenge is one of the defining healthcare stories of the next decade. Whether AI digital therapeutics can meet that challenge at the scale and speed the demographics demand is still an open question. Drop your take in the comments below.
Sources & Further Reading
